Ceramide synthase 1 is regulated by proteasomal mediated turnover.
暂无分享,去创建一个
P. Sridevi | M. Hannink | A. Futerman | Elad L. Laviad | S. Alexander | Y. Pewzner‐Jung | Hannah Alexander
[1] G. Meer,et al. Membrane lipids: where they are and how they behave , 2008, Nature Reviews Molecular Cell Biology.
[2] Yusuf A. Hannun,et al. Principles of bioactive lipid signalling: lessons from sphingolipids , 2008, Nature Reviews Molecular Cell Biology.
[3] Y. Hannun,et al. A novel role for protein kinase Cδ‐mediated phosphorylation of acid sphingomyelinase in UV light‐induced mitochondrial injury , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[4] Y. Hannun,et al. Involvement of sphingoid bases in mediating reactive oxygen intermediate production and programmed cell death in Arabidopsis , 2007, Cell Research.
[5] A. Haimovitz-Friedman,et al. Kinetic characterization of mammalian ceramide synthases: Determination of K m values towards sphinganine , 2007, FEBS letters.
[6] P. V. Van Veldhoven,et al. (Dihydro)ceramide Synthase 1–Regulated Sensitivity to Cisplatin Is Associated with the Activation of p38 Mitogen-Activated Protein Kinase and Is Abrogated by Sphingosine Kinase 1 , 2007, Molecular Cancer Research.
[7] A. Huwiler,et al. Targeting the conversion of ceramide to sphingosine 1-phosphate as a novel strategy for cancer therapy. , 2007, Critical reviews in oncology/hematology.
[8] L. Obeid,et al. Alterations of Ceramide/Sphingosine 1-Phosphate Rheostat Involved in the Regulation of Resistance to Imatinib-induced Apoptosis in K562 Human Chronic Myeloid Leukemia Cells* , 2007, Journal of Biological Chemistry.
[9] F. Goñi,et al. Sphingolipids and cell death , 2007, Apoptosis.
[10] Y. Hannun,et al. Role of human longevity assurance gene 1 and C18-ceramide in chemotherapy-induced cell death in human head and neck squamous cell carcinomas , 2007, Molecular Cancer Therapeutics.
[11] Y. Hannun,et al. Protein Kinase C-induced Activation of a Ceramide/Protein Phosphatase 1 Pathway Leading to Dephosphorylation of p38 MAPK* , 2006, Journal of Biological Chemistry.
[12] Y. Hannun,et al. Necessary Role for the Lag1p Motif in (Dihydro)ceramide Synthase Activity* , 2006, Journal of Biological Chemistry.
[13] A. Kihara,et al. LASS3 (longevity assurance homologue 3) is a mainly testis-specific (dihydro)ceramide synthase with relatively broad substrate specificity. , 2006, The Biochemical journal.
[14] Howard Riezman,et al. Transmembrane topology of ceramide synthase in yeast. , 2006, The Biochemical journal.
[15] S. Ben-Dor,et al. When Do Lasses (Longevity Assurance Genes) Become CerS (Ceramide Synthases)? , 2006, Journal of Biological Chemistry.
[16] P. Krzyzanowski,et al. Protection of glioblastoma cells from cisplatin cytotoxicity via protein kinase Cι-mediated attenuation of p38 MAP kinase signaling , 2006, Oncogene.
[17] D. Goldenberg,et al. Sphingolipid targets in cancer therapy , 2006, Molecular Cancer Therapeutics.
[18] S. D'souza,et al. E2F1 stability is regulated by a novel-PKC/p38β MAP kinase signaling pathway during keratinocyte differentiation , 2006, Oncogene.
[19] A. Futerman,et al. LASS5 Is a Bona Fide Dihydroceramide Synthase That Selectively Utilizes Palmitoyl-CoA as Acyl Donor* , 2005, Journal of Biological Chemistry.
[20] C. Ong,et al. Protein kinase C inhibition and x-linked inhibitor of apoptosis protein degradation contribute to the sensitization effect of luteolin on tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in cancer cells. , 2005, Cancer research.
[21] A. Kihara,et al. Mammalian Lass6 and its related family members regulate synthesis of specific ceramides. , 2005, The Biochemical journal.
[22] K. Conklin. Chemotherapy-Associated Oxidative Stress: Impact on Chemotherapeutic Effectiveness , 2004, Integrative cancer therapies.
[23] Y. Hannun,et al. Defects in Cell Growth Regulation by C18:0-Ceramide and Longevity Assurance Gene 1 in Human Head and Neck Squamous Cell Carcinomas* , 2004, Journal of Biological Chemistry.
[24] A. Merrill,et al. Two Mammalian Longevity Assurance Gene (LAG1) Family Members, trh1 and trh4, Regulate Dihydroceramide Synthesis Using Different Fatty Acyl-CoA Donors* , 2003, Journal of Biological Chemistry.
[25] S. Y. Cajal,et al. Role of the p38 MAPK pathway in cisplatin-based therapy , 2003, Oncogene.
[26] H. Riezman,et al. Upstream of Growth and Differentiation Factor 1 (uog1), a Mammalian Homolog of the Yeast Longevity Assurance Gene 1 (LAG1), RegulatesN-Stearoyl-sphinganine (C18-(Dihydro)ceramide) Synthesis in a Fumonisin B1-independent Manner in Mammalian Cells* , 2002, The Journal of Biological Chemistry.
[27] Yusuf A. Hannun,et al. The Ceramide-centric Universe of Lipid-mediated Cell Regulation: Stress Encounters of the Lipid Kind* , 2002, The Journal of Biological Chemistry.
[28] N. Holbrook,et al. Requirement for ERK Activation in Cisplatin-induced Apoptosis* , 2000, The Journal of Biological Chemistry.
[29] K. Knudsen,et al. RB-Dependent S-Phase Response to DNA Damage , 2000, Molecular and Cellular Biology.
[30] S. Spiegel,et al. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate , 1996, Nature.
[31] Richard A. Lerner,et al. Immunogenic structure of the influenza virus hemagglutinin , 1982, Cell.
[32] P. Galle,et al. The longevity assurance homologue of yeast lag1 (Lass) gene family (review). , 2009, International journal of molecular medicine.
[33] S. Saddoughi,et al. Roles of bioactive sphingolipids in cancer biology and therapeutics. , 2008, Sub-cellular biochemistry.
[34] Kyong-Tai Kim,et al. Protein kinase Cdelta-mediated proteasomal degradation of MAP kinase phosphatase-1 contributes to glutamate-induced neuronal cell death. , 2006, Journal of cell science.